Clinical trials are evolving, and so should the technology that empowers them. Modern Digital Health Technologies (DHTs) should be reducing costs and enhancing the participant experience, while providing reliable, high-quality data.
Watch our webinar recording for an in-depth look at EmbraceMini, our newest actigraphy wearable designed to solve some of the biggest challenges in decentralized and hybrid trials.
From improving participant compliance to reducing site burden and integration headaches, EmbraceMini delivers medical-grade data in a cost-effective package and a sleek, discreet form factor that participants can wear next to their favorite accessory or watch.
What to expect:
Request access today to get an exclusive look at EmbraceMini and discover how it can make your next trial more efficient and participant-friendly.
Empatica is a pioneer in digital biomarker development and continuous health monitoring driven by AI.
Its FDA-cleared platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. Its flagship medical wearable, EmbracePlus, has been developed with key partners including HHS, USAMRDC, and the NASA-funded TRISH.